...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

Hummmmmm,,I wonder if DMcC just received this covid data early this morning or did he have it a while back and saved the news until this morning for release??  Or can Companies hoard material information and release such when they want?? Some members here believe they are not allowed to hoard,,,seems perfectly obvious this is an attempt at damage control prior to the AGM. Another partner needed of course..timing for this trial is most likely years off,,we will be in the midst of a different pandemic by that time. The excitment is building in Calgary,, I can feel it,,cant you! The team may wet their depends for sure this time!

Share
New Message
Please login to post a reply